Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 2,307 | 1,716 | 1,617 | 2,029 | 2,270 |
| Operating Income | -2,307 | -1,716 | -1,617 | -2,029 | -2,270 |
| Other Income | 53 | 35 | 39 | 36 | 23 |
| Pre-tax Income | -2,254 | -1,681 | -1,578 | -1,993 | -2,246 |
| Net Income Continuous | -2,254 | -1,681 | -1,578 | -1,993 | -2,246 |
| Net Income | $-2,254 | $-1,681 | $-1,578 | $-1,993 | $-2,246 |
| EPS Basic Total Ops | -0.53 | -0.62 | -0.05 | -1.23 | -1.89 |
| EPS Basic Continuous Ops | -0.53 | -0.62 | -0.06 | -1.23 | -1.89 |
| EPS Diluted Total Ops | -0.53 | -0.62 | -0.05 | -1.23 | -1.89 |
| EPS Diluted Continuous Ops | -0.53 | -0.62 | -0.06 | -1.23 | -1.89 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.62 | -0.31 | -1.23 | -1.89 |
| EBITDA(a) | $-2,307 | $-1,716 | $-1,617 | $-2,029 | $-2,270 |